| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | CA2582317A1 The use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1644015A1 Plant extraction method and extract |
| 04/12/2006 | EP1644014A1 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 04/12/2006 | EP1409513B1 Methylene-4-azasteroids |
| 04/12/2006 | EP1355639B1 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1041880A4 A delivery of arginine to cause beneficial effects |
| 04/12/2006 | CN2770654Y Direct-administering stick |
| 04/12/2006 | CN1758919A Compositions comprising hyaluronic acid for the prevention of urogenital infections |
| 04/12/2006 | CN1757404A Composite traditional Chinese medicine for treating metritis, and its prepn. method |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 04/12/2006 | CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250282C Stable protein compositions |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250266C Method for preparing Chinese medicine preparation for treating gynecopathy |
| 04/12/2006 | CN1250264C Capsule for curing hyperplasia of mammary glands and its preparation method |
| 04/12/2006 | CN1250261C Chinese traditional medicine for treating male infertility |
| 04/12/2006 | CN1250249C External used Chinese traditional medicine lotion for treating gynaecologic inflammation |
| 04/12/2006 | CN1250247C Luyang kidney yang strengthening Chinese traditional medicinal formula and its preparation |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/12/2006 | CN1250222C Praziquantel composition for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 04/12/2006 | CN1250221C Treatment of female sexual dysfunction |
| 04/11/2006 | US7026516 Compounds with high monoamine transporter affinity |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026349 Sulfonamides |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/11/2006 | US7026300 One step immunization procedure for inducing a Chlamydia specific immune response |
| 04/11/2006 | CA2411008C Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
| 04/11/2006 | CA2335582C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
| 04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 04/06/2006 | WO2006036055A2 Method of female contraception and kit for use in such method |
| 04/06/2006 | WO2006035974A1 Oligoribonucleotide |
| 04/06/2006 | WO2005051799A3 Peptide increasing fusiogenic capacity of a gamete |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074107 Pharmaceutically active piperidine derivatives |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074027 Microcapsules of luteinizing hormone releasing hormone agonists; glycolic acid-lactic acid copolymers; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, precocious puberty, dymenorrhea or breast cancer, or inhibiting conception |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073516 Novel screening method |
| 04/06/2006 | US20060073166 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR |
| 04/06/2006 | DE60202958T2 Stabiles polymorph von flibanserin, industrielles verfahren zu dessen herstellung und dessen verwendung zur herstellung von medikamenten Stable polymorph of flibanserin, industrial process for its production and its use for the preparation of medicaments |
| 04/06/2006 | DE102004042441A1 Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel With amino acids substituted hexahydro-pyrazino (1,2-a) pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments |
| 04/06/2006 | CA2581932A1 A method of female contraception and a kit for use therein |
| 04/06/2006 | CA2581769A1 Methods of using chimeric coiled-coil molecule |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1642587A1 Follicle-stimulating hormone releasing agent |
| 04/05/2006 | EP1642584A1 External preparation for improving coital function |
| 04/05/2006 | EP1641824A1 Relaxin superfamily peptide analogues |
| 04/05/2006 | EP1641794A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer |
| 04/05/2006 | EP1641792A1 Pyrrolodihydroisoquinolines as pde10 inhibitors |
| 04/05/2006 | EP1641745A1 Propionamide derivatives useful as androgen receptor modulators |
| 04/05/2006 | EP1641470A1 Vaginal compositions for treating pelvic tissue infections and traumas |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1372680B1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP1051162B1 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate |
| 04/05/2006 | CN1756746A 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 04/05/2006 | CN1754568A Artificial hymen |
| 04/05/2006 | CN1754561A Medicine for promoting children sexual development |
| 04/05/2006 | CN1754544A Gound beetle extractions extracted from different parts and heat-free extraction process |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1248738C Testosterone ester formulation for human use |
| 04/05/2006 | CN1248732C Embonate medicine composition containing bombesin-like product |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022847 Reacting benzamide derivative with haloketone compound to form imidazotriazine compound |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 04/04/2006 | US7022707 such as S-4-[(2-propylamino)carbonyl]oxybenzyl piperazine-1-thiocarboxylate for treatment of obesity and/or diabetes |
| 04/04/2006 | US7022699 Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 03/30/2006 | WO2006033950A1 Lactobacillus and atopobium compositions for maintaining and restoring normal urogenital flora |
| 03/30/2006 | WO2006033949A1 Lactobacillus iners for reduction of human malodor |
| 03/30/2006 | WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE |
| 03/30/2006 | WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | US20060069259 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069031 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation |
| 03/30/2006 | US20060068045 Method for the preparation of phytoprogestogenic extracts from rhizoma ligusticum chuanxiong and uses thereof |